|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1998-11-5
|
|
pubmed:abstractText |
The purpose of this study was to test the disease-controlling effect of low-dose oral etoposide monotherapy in adult-onset multisystem Langerhans cell histiocytosis. There are no previous reports of low-dose etoposide monotherapy for this condition.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0003-987X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
134
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1275-8
|
|
pubmed:dateRevised |
2008-3-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9801684-Administration, Oral,
pubmed-meshheading:9801684-Adult,
pubmed-meshheading:9801684-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:9801684-Chronic Disease,
pubmed-meshheading:9801684-Drug Administration Schedule,
pubmed-meshheading:9801684-Etoposide,
pubmed-meshheading:9801684-Histiocytosis, Langerhans-Cell,
pubmed-meshheading:9801684-Humans,
pubmed-meshheading:9801684-Male
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Low-dose oral etoposide monotherapy in adult Langerhans cell histiocytosis.
|
|
pubmed:affiliation |
Department of Dermatology, Martin-Luther-Universität Halle-Wittenberg, Germany. peter.helmbold@medizin.uni-halle.de
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
